2 Minutes with Joey - LLY Stock News

Epizódy

• LLY Today - Jul 19: Biotech Bet Boosts Stock 19.07.2026 1min

  Hey there! It’s Joey here, your go-to guy for stock talk. I’ve been in the investing game for a while, and today we’re checking out Eli Lilly, ticker LLY. So, how’d it do? Well, it was a green day, up about 0.85%. Not a huge jump, but hey, it’s still in the green!Now, what happened? The stock saw a bit of a boost, hitting its highest point in over two months. It’s been pretty steady, and it looks like people are feeling good about it. There’s been a lot of chatter around Eli Lilly lately, especially with their new biotech moves. They’ve made a $3 billion deal, and that’s got folks excited. It’s kind of like when you find a hidden gem at a thrift store — you just know it’s worth more than what you paid.So, why the buzz? Well, it seems Eli Lilly is looking pretty undervalued right now, according to some analysts. They’re saying the stock could be about 20% below its fair value after that big deal. That’s got a lot of investors thinking it might be a good time to jump in. Plus, with their upcoming data on retatrutide, a new drug, people are keeping a close eye on how that plays out. It’s like waiting for the next season of your favorite show to drop — everyone’s curious!Oh, and one more thing to keep in your back pocket: Eli Lilly is finding key support levels in the market, which could help keep it stable for a bit. It’s always nice when a stock can find its footing, right?So, to wrap this up, Eli Lilly had a solid day, with some promising developments on the horizon. Just remember, I’m here for the info and entertainment — not giving any buy or sell advice. Keep your eyes peeled, and happy investing!
• LLY Today - Jul 18: Eli Lilly's Steady Surge 18.07.2026 1min

  Hey there! It’s Joey, your friendly stock enthusiast, here to break down what went down with Eli Lilly today. So, LLY had a solid day, up about 0.85%. Not a huge jump, but hey, a win’s a win, right?Now, let’s get into it. The stock kinda hovered around that $1,179 mark, which is nice and stable. You know, just chilling. It seems like people are still feeling pretty good about Eli Lilly, especially with all the buzz around their recent moves. So, why’s everyone so pumped? Well, it looks like Eli Lilly’s been getting some serious attention for reasons that aren’t just about weight loss. Yeah, that’s right! While they’ve been known for their weight loss drugs, there’s a lot more brewing under the surface. Reports are saying they’re making some smart plays in the market, and analysts are pointing out that their growth momentum is pretty solid. They’ve also got this $3 billion deal cooking, and that’s got folks excited. UBS even gave a thumbs up on their recent acquisition of ATAI, which is a big deal. It’s like they’re stacking up their game and making moves that could really pay off in the long run. Plus, there’s chatter about the Wegovy pill shaking up the GLP-1 market, and it looks like Eli Lilly could still come out on top. One thing to keep an eye on is that Eli Lilly’s growth momentum seems to be holding strong, and they’re finding key support levels. That’s like a safety net for the stock, which is always nice to see.So, to wrap it up, Eli Lilly had a steady day, and there’s a lot of positive energy around them right now. They’re making some strategic moves that could keep the momentum going. Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
• LLY Today - Jul 17: Eli Lilly's Big Buyout Buzz 17.07.2026 1min

  Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in this game for a while, and today we’re talking about Eli Lilly, or LLY for short. So, was it a green day or a red day? Well, it was a green day, barely up by about 1.15%. So, here’s the scoop. LLY is buzzing today, and it’s all about that big acquisition news. They’re in the process of buying AtaiBeckley, a psychedelic drugmaker, for up to $3.8 billion. Yeah, that’s a hefty price tag! This news got people excited and it pushed the stock up a little. I mean, who doesn’t love a good growth story, right? But just a heads up, the trading volume was pretty low compared to its average. So, not a wild ride, but still a nice little bump.Now, why did this matter? Well, investors are super into the potential of psychedelic treatments these days. Eli Lilly is trying to expand its portfolio, and this acquisition could open up new doors for them. It’s part of their strategy to tap into some high-growth markets. UBS even chimed in, saying they’re keeping their rating on Eli Lilly solid, all thanks to this acquisition. So, it’s like a vote of confidence from the pros.Looking ahead, it’s worth mentioning that Eli Lilly is also working on some other projects in the pipeline, so there’s definitely more to keep an eye on here. But honestly, today was all about that AtaiBeckley buzz.Alright, that’s the lowdown on Eli Lilly for today. Just remember, this is all for fun and information—definitely not financial advice. Catch you later!
• LLY Today - Jul 16: Eli Lilly's Big Psychedelic Deal 16.07.2026 1min

  Hey there! It's Joey here, your friendly neighborhood investor, breaking down the day for you. Today, we're talking about Eli Lilly, and guess what? It was a green day, up about 1.4%. Not a massive jump, but hey, a win's a win, right?So, what went down? Eli Lilly just announced they’re scooping up a psychedelic drug company called AtaiBeckley for a cool $2.8 billion. Yeah, you heard that right! This is a big move for Lilly, and it’s got folks buzzing. AtaiBeckley’s stock skyrocketed by 31% after the news hit. People are all about those experimental treatments these days, and it looks like Lilly's trying to get in on that action. Now, why did this matter so much? Well, it’s all about the future of medicine, man. Psychedelics are gaining traction in the treatment world, and Lilly wants to be a player in that space. They’re betting on these experimental treatments becoming the next big thing, and honestly, it’s a pretty bold step. Investors seem to think it could pay off, which is why we saw some positive movement in Lilly’s stock today. One more thing to keep an eye on: there’s chatter that Lilly’s stock might actually be undervalued after their recent FDA approval for a cancer drug. So, yeah, they might have more room to grow if that plays out well.Alright, that’s a wrap for today! Just remember, this is all for your info and fun, not financial advice. Catch you later!
• LLY Today - Jul 15: Small Dip Amid Market Gains 15.07.2026 1min

  Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Eli Lilly today. So, LLY had a bit of a rough day, slipping about 1.2%. Yeah, that one stung.Now, let’s talk about what happened. While the overall market was on the upswing, LLY decided to take a step back. The volume was way lower than usual, too. People weren’t really rushing to buy or sell, which is kinda telling. So, why the dip? Well, there wasn’t a major news bomb that dropped, but it seems like investors are just taking a breather after a pretty solid run. There was chatter about Eli Lilly's performance compared to its peers, and it looks like some folks are getting cautious. Plus, there’s a lot of buzz about its future potential. Bernstein even raised the stock price target, which usually means someone’s feeling optimistic. But today? Not so much. Oh, and here’s a fun fact: Eli Lilly has been a solid performer for a while now. Back in 2020, the Atlas Healthcare Fund got in at around $350. Now, it’s trading over $1,200! Wild, right? To wrap it up, Eli Lilly took a small dip today while the market was cruising. It's a reminder that even good stocks have their off days. Just keep an eye on the future, as there’s still a lot of potential there. Remember, this is just for fun and info, not financial advice. Catch you later!
• LLY Today - Jul 14: Stock Takes a Dip 14.07.2026 1min

  Hey there! It’s Joey here, your friendly neighborhood investor. Let’s chat about Eli Lilly today. It was a red day for LLY, down about 2.7%. Ouch!So, what happened? Well, the stock got smoked, dropping over 30 bucks. Not the best news, right? The volume was pretty low, too, which usually means people are sitting on the sidelines. Now, why did this happen? There’s a lot of chatter in the market. Bernstein raised their price target, which is usually a good sign. They see potential for Lilly to beat expectations. But then there’s this disturbing trend in the obesity drug market that’s got some folks worried. The competition is heating up, and that’s making investors a bit nervous. It’s kinda like when you’re in a race, and suddenly, everyone else speeds up. You start to sweat a little, ya know?Also, some predictions out there say Lilly could still hit a much higher price down the line, like $2,090. That’s wild! But with all this back-and-forth, it’s hard to know what to think. Some say things are looking good, while others are feeling cautious. It’s a mixed bag right now.One thing to keep an eye on is how Lilly performs in the next earnings report. That’s always a big deal. If they can show strong sales momentum, it could change the game.So, that’s the scoop on Eli Lilly today. It’s a bit of a rollercoaster, but hey, that’s the stock market for you! Just remember, this is all for fun and info, not financial advice. Catch you later!
• LLY Today - Jul 13: Analyst Upgrades Boost Sentiment 13.07.2026 1min

  Hey there! It’s Joey, your friendly neighborhood investor, here to break down how Eli Lilly did today. Spoiler alert: it was a bit of a green day, up just a smidge at 0.22%. So, what happened? Well, LLY didn’t exactly have fireworks today, but it didn’t crash and burn either. It kinda just hung around, barely moving. The trading volume was way lower than usual, which usually means people weren’t really rushing to buy or sell. Now, why did it move this way? A couple of things were buzzing in the news. Analysts are feeling pretty optimistic about Eli Lilly, especially with the buzz around their new weight-loss drugs and some recent data they presented at a conference. Guggenheim even raised their price target on the stock, which is usually a good sign. People are chatting about how these drugs could really change the game for investors, and that’s got some folks excited. But honestly, the stock’s not moving in wild swings like it has in the past. It seems like investors are kinda waiting to see what’s next.Speaking of what's next, Eli Lilly's got some new data on a drug called Kisunla that they just presented. It’s creating a bit of a stir, so keep an eye on that. It could shake things up in the near future.Alright, that’s the scoop for today! Eli Lilly is hanging in there, and it looks like analysts are still pretty positive. Just remember, this is all for fun and info—no financial advice here. Catch you later!
• LLY Today - Jul 12: Bearish Options Activity 12.07.2026 1min

  Hey there! It's Joey, your friendly investor buddy. Just breaking down the day for you. Today, we’re talking about Eli Lilly, and spoiler alert: it was a red day. The stock dropped about 2.3%. Ouch, right?So, what happened? LLY got smoked today, dropping by more than 28 bucks. It seems like some investors were hitting that sell button pretty hard. The stock's been on a bit of a rollercoaster lately, and today was definitely not a good ride. Now, why did it happen? Well, some chatter around bearish options activity is making folks a bit jittery. Basically, that means a lot of people are betting against the stock, which can really shake things up. There’s this vibe that the market isn’t feeling super confident about Eli Lilly right now. And if you check out the news, some articles are hinting that people are wondering if it’s time to buy, sell, or just hold tight. It’s a mixed bag of opinions out there. Also, there’s some buzz around Eli Lilly sharing new data on Kisunla and a blood test for Alzheimer’s at an upcoming conference. That could be a big deal, but today, it wasn’t enough to keep the stock from sliding. So, yeah, that one stung for LLY today. Just remember, this is all for fun and info—no financial advice here! Catch you later!
• LLY Today - Jul 11: Mixed signals on growth 11.07.2026 1min

  Hey there! It’s Joey here, your friendly neighborhood investor. Today, we’re breaking down Eli Lilly, and spoiler alert: it was a red day. The stock dipped about 2.3%. Ouch!So, what went down? Well, LLY got smoked today, losing some ground after a pretty mixed bag of news. It opened strong but then drifted down as the day went on. People were hitting that sell button pretty fast, which isn’t the best sign.Now, why the drop? There’s chatter about Eli Lilly's premium valuation. Some folks are wondering if it’s really justified given the current growth story. Yeah, that one stung. They’ve got some new data coming out for their Kisunla treatment and an Alzheimer’s blood test, but it seems like investors are a bit skeptical. Plus, their new Foundayo launch hasn’t exactly been setting the world on fire. It’s been described as “muted,” which doesn’t sound too exciting, right?On the horizon, they’re gearing up to share that new data at the Alzheimer’s Association International Conference. So, that could shake things up a bit, depending on how it goes.To wrap it up, today wasn’t Eli Lilly’s best day. With some mixed signals on growth and a bit of investor hesitation, it’s clear why the stock took a hit. Just remember, this is all for fun and info, not financial advice. Catch you later!
• LLY Today - Jul 10: Stock Slumps on Market Sentiment 10.07.2026 1min

  Hey there! It’s Joey, your friendly investor buddy, breaking down the day’s stock action. Today, we’re talking about Eli Lilly. Spoiler alert: it was a red day. The stock dropped about 2.7%. Ouch!So, what happened? Well, LLY got smoked today, losing a good chunk of its value. It wasn’t just a little dip; it felt like a slow bleed. Volume was lower than usual, too, which usually means people were kinda just sitting this one out.Now, why did this happen? A couple of articles pointed to some market sentiment issues. There’s a lot of chatter about Eli Lilly’s future growth, especially with their obesity drug business. While that part is booming, folks seem to be worried about how the overall market is reacting to earnings reports from other companies. You know how it goes—when the bigger market shakes, even solid stocks can feel the tremors. One article mentioned that analysts are still pretty bullish on Lilly’s growth, which is a good sign. But right now, it feels like investors are playing it safe and not taking any chances. Nobody really knows for sure why today was such a rough ride, but the market can be unpredictable like that.Oh, and just so you know, Eli Lilly’s obesity drug growth is still impressive, and they’re seeing success globally. That’s something to keep an eye on, for sure!Alright, folks, that’s a wrap on Eli Lilly today. Just remember, this is all for fun and info, not financial advice. Stay curious and keep those questions coming! Catch you later!
• LLY Today - Jul 09: Slight Move Amid Mixed Signals 09.07.2026 1min

  Hey there! It’s Joey, your friendly investor buddy, and I’m here to break down what went down with Eli Lilly today. So, LLY had a pretty chill day, barely moving—up just a smidge, like 0.25%. So, what happened? Well, the stock kinda just floated around today. It didn’t get smoked, but it wasn’t exactly a party either. Volume was low, too, like way below the average. Seems like folks were keeping it close to the chest, maybe waiting for some juicy news or a spark.Now, why did Eli Lilly see this slight uptick? The buzz has been all about predictions and comparisons. Some articles are saying that LLY could hit some nice price points by the end of 2026, which might’ve given a little boost to the stock. Plus, there’s chatter about how Eli Lilly stacks up against other investments, like SpaceX. Some folks think it’s a better bet right now, which could be stirring up some interest. And here’s a little nugget for you: there’s some talk about how Eli Lilly is expected to keep pushing forward with their products and research, so that’s something to keep an eye on. So, all in all, today was just a quiet day for LLY, but there’s still a lot of chatter happening in the background. Remember, I’m just here to share what’s up, not to give any financial advice. Catch you later!
• LLY Today - Jul 09: Small Move, Big Questions 09.07.2026 1min

  Hey there! It’s Joey here, your friendly neighborhood investor, breaking down the stock scene for today. We’re chatting about Eli Lilly, and it was kind of a mixed bag—LLY was barely in the green, up just a smidge, around a quarter percent. So, what went down? The stock didn’t really make waves today. It was one of those days where it just sort of floated along. Volume was way below average, so not a lot of action there. It seems like folks were just chillin’ instead of diving in. Now, why did it move like this? Well, there’s chatter in the air. Some articles are pointing out that Eli Lilly is still seen as a solid player in the market, especially compared to other stocks, like SpaceX. That sounds pretty wild, right? People are weighing their options, and some think LLY is a better pick right now. But then there are those predictions floating around about where the stock might land by the end of 2026. Honestly, it’s a mixed bag of opinions, and nobody really knows what’s going to happen next. One thing worth keeping an eye on is the wide divide in opinions about LLY’s future. Some think it’s got a bright road ahead, while others are a bit more skeptical. That split could make things interesting as we move forward. Alright, that’s a quick rundown for you! Remember, I’m just here to give you the scoop, not tell you what to do with your money. Stay smart, stay curious, and I’ll catch you next time!
• LLY Today - Jul 08: Stock Faces Some Headwinds 08.07.2026 1min

  Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today we’re chatting about Eli Lilly, which had a bit of a rough ride. It closed down about 1.6%. Yeah, that one stung.So, what went down? The stock started the day strong but couldn’t hold onto those gains and ended up falling. It felt like a slow bleed as the day went on. There was some buzz about whether it’s too late to jump into Eli Lilly, and that might’ve had folks hitting the sell button. Now, why the drop? Well, it seems like investors are still wrestling with the stock's valuation. Some articles pointed out that even with rich earnings, it might still be trading below fair value. And there’s chatter about the wide divide ahead for Eli Lilly, which is making people a bit nervous. Plus, there was a price target raise from Truist based on strength in their incretin products, but that may not have been enough to inspire confidence today.On the horizon, there’s talk about predictions for where Eli Lilly stock could be headed by the end of 2026. So, folks are definitely keeping an eye on that.Alright, that’s the scoop! Just remember, this is all for info and entertainment, not financial advice. Catch you later!
• LLY Today - Jul 07: Stock Hits All-Time High 07.07.2026 1min

  Hey there! It's Joey, your friendly investor buddy. Today, we’re talking about Eli Lilly, and guess what? It was a green day! The stock was up about 2.9%, which is pretty cool.So, here’s the scoop. LLY hit an all-time high today, reaching around 1238 bucks. Yeah, that one stung for anyone who didn’t jump in earlier! It seems like investors are feeling pretty optimistic about the stock lately. The buzz seems to be around the potential value of the company, especially with the whole Medicare GLP-1 expansion thing. A lot of folks think LLY could actually be undervalued by a good chunk—like 19%. That’s a solid reason for people to be excited, right?But let’s be real. The market’s a bit of a rollercoaster, and today’s action was also influenced by chatter about earnings expectations. Traders are always speculating how LLY will perform in the next report. If they nail it, we might see even more movement. But, honestly, nobody really knows how it'll play out.Now, one thing to keep on your radar is that there’s been a lot of talk about whether it’s too late to get in on Eli Lilly. Some articles are throwing around ideas about what a thousand bucks could turn into in ten years if you invest now. It's wild to think about the long game, but remember, investing is always a bit of a gamble.So, to wrap it up, Eli Lilly had a solid day, hitting that all-time high and keeping investors buzzing. Just keep in mind, this is all for your info and entertainment—definitely not financial advice. Catch you later!
• LLY Today - Jul 06: Slight Dip Amidst Buzz 06.07.2026 1min

  Hey there! It’s Joey here, your friendly neighborhood investor. I've been in the game for a while, and today we're checking in on Eli Lilly, or LLY for short. It was a bit of a red day for the stock, down almost a percent. Yeah, not the best news.So, what went down? LLY dropped about 9.61 bucks today. Not a huge blowout, but enough to make you go, "Hmm." The trading volume was way below average, which usually means folks were kinda chill about it. Now, why did this happen? Well, honestly, it’s a bit of a mixed bag. There’s a lot of chatter about Eli Lilly's future, with some articles talking about how buying the stock could set you up for life. But despite all that positive spin, the stock still took a hit. Some analysts are saying it’s all good because Cantor Fitzgerald even raised their price target, but that didn’t seem to spark any buying frenzy. And then there’s this whole thing about Novo Nordisk and their flashy Ozempic and Wegovy price cuts. BofA thinks those won’t really mess with LLY, but who knows, right? Looking ahead, there’s chatter about Eli Lilly’s drug pipeline and Medicare coverage, which could be a game-changer for them. Folks are keeping an eye on that for sure. So, to wrap it up, LLY had a rough day, but the buzz around its future is still pretty loud. Just remember, I’m here to share the info, not to give financial advice. Keep it chill, and catch you later!